Shilpa Medicare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shilpa Medicare Limited has submitted a disclosure to the stock exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation pertains to disclosures related to encumbered (pledged) shares by the promoter. The filing itself does not specify whether the disclosure relates to the creation, invocation, or release of an encumbrance on promoter-held shares. Investors should refer to the actual disclosure document for specific details on the nature and extent of the pledge-related change.
Since the details of the disclosure (whether new pledge, invocation, or release) are not specified in this filing, the immediate impact on shareholders is unclear. Investors should monitor for the full disclosure to assess any implications for promoter shareholding and stock price.